VP
ABBV icon

Verisail Partners’s AbbVie ABBV Stock Holding History

Verisail Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Buy
1,202
+2
+0.2% +$430 0.11% 19
2026
Q1 		$261K Hold
1,200
– – 0.11% 19
2025
Q4 		$274K Hold
1,200
– – 0.11% 20
2025
Q3 		$278K Hold
1,200
– – 0.12% 18
2025
Q2 		$223K Buy
+1,200
New +$223K 0.09% 32

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Verisail Partners's ABBV Position: Q2 2026 in Review

Verisail Partners increased its AbbVie (ABBV) stake by 0.17% in Q2 2026, buying an estimated $430 and bringing the position to 1,202 shares worth $302K. The position accounts for 0.11% of the portfolio, ranked #19.

Verisail Partners first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 3,254 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Verisail Partners held 1,202 shares of AbbVie worth $302K as of Q2 2026.
  • Verisail Partners bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.11% of Verisail Partners's portfolio in Q2 2026, its #19 holding.
  • Verisail Partners first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 3,254 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Verisail Partners's 13F filing for Q2 2026, filed 14 Jul 2026.